Development
iShares Biotechnology ETF
IBB
NASDAQ
| Weiss Ratings | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Valuation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $116.21 | |||
| Company Info | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | iShares | |||
| Manager/Tenure (Years) | Greg Savage (17), Jennifer Hsui (12), Paul Whitehead (3) | |||
| Website | http://www.ishares.com | |||
| Phone Number | 800-474-2737 | |||
| Fund Information | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | iShares Biotechnology ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Technology | |||
| Inception Date | Feb 05, 2001 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.30% | |||
| Dividend | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.54% | |||
| Asset Allocation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.00% | |||
| Stock | 100.00% | |||
| U.S. Stock | 90.65% | |||
| Non-U.S. Stock | 9.35% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -9.70% | |||
| 30-Day Total Return | -11.71% | |||
| 60-Day Total Return | -14.54% | |||
| 90-Day Total Return | -10.80% | |||
| Year to Date Total Return | -10.33% | |||
| 1-Year Total Return | -11.09% | |||
| 2-Year Total Return | -8.18% | |||
| 3-Year Total Return | -10.31% | |||
| 5-Year Total Return | 12.85% | |||
| Price | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $124.44 | |||
| 1-Month Low Price | $124.44 | |||
| 1-Month High Price | $136.95 | |||
| 52-Week Low Price | $124.44 | |||
| 52-Week Low Price (Date) | Apr 01, 2025 | |||
| 52-Week High Price | $149.47 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| NAV | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $124.48 | |||
| 1-Month High NAV | $136.83 | |||
| 52-Week Low NAV | $124.48 | |||
| 52-Week Low NAV (Date) | Apr 01, 2025 | |||
| 52-Week High NAV | $149.39 | |||
| 52-Week High Price (Date) | Sep 19, 2024 | |||
| Beta / Standard Deviation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | 17.88 | |||
| Balance Sheet | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 5.81B | |||
| Operating Ratios | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.45% | |||
| Turnover Ratio | 22.00% | |||
| Performance | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 11.77% | |||
| Last Bear Market Total Return | -9.59% | |||